ArticleNeuro-oncology2025

Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype.

Maura Massimino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.